Arcus Biosciences (RCUS) Earnings Date & Reports

Arcus Biosciences Inc is a late clinical-stage biopharmaceutical company focused on developing differentiated molecules for patients with cancer and inflammatory and autoimmune diseases... Show more

Industry: #Pharmaceuticals Major

Get AI intraday signals

A.I. Advisor

published Earnings

RCUS is expected to report earnings to fall 11.36% to -90 cents per share on August 12

Arcus Biosciences RCUS Stock Earnings Reports

Q2'26

Est.

$-0.90

Q1'26

Missed

by $0.17

Q4'25

Beat

by $0.21

Q3'25

Beat

by $0.01

Q2'25

Beat

by $1.12

The last earnings report on May 05 showed earnings per share of -101 cents, missing the estimate of -85 cents. With 112.27K shares outstanding, the current market capitalization sits at 3.42B.

View a ticker or compare two or three

Compare

RCUS

Setup

Daily Signal:

Description

Gain/Loss:

Interact to see
Advertisement

A.I.Advisor

published price charts

Last 5 trading days

View AI-Driven Trading for RCUS